Regeneron Pharmaceuticals (REGN) Intangibles (2021 - 2026)
Regeneron Pharmaceuticals (REGN) reported Intangibles of $1.31 billion for Q2 2026, down 3.1% from $1.35 billion a year earlier but up 1.8% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Intangibles (2021 - 2026) Analysis & Trends
At the end of FY2025, Regeneron Pharmaceuticals posted Intangibles of $1.26 billion, up 9.5% from FY2024.
- Intangibles has increased for three consecutive years, with a four-year compound annual growth rate of 270.1% (FY2021 to FY2025).
- By year, Intangibles came in at $1.15 billion in FY2024 (+10.6%), $1.04 billion in FY2023 (+13.4%), $915.5 million in FY2022 and $6.7 million in FY2021.
- Five-year quarterly Intangibles spans a low of $6.7 million in Q4 2021 and a high of $1.38 billion in Q3 2025.
- Year over year, Intangibles gained in seven of the last eight quarters, with growth averaging 11.7%.
- The high point for year-over-year Intangibles in five years was Q3 2025 (growth of 23.3%); the low point was Q2 2026 (a decline of 3.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.29 billion (Q1 2026), $1.26 billion (Q4 2025) and $1.38 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 48.23 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | 1.31 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.31 Bn |
| Mar 31, 2026 | 1.29 Bn |
| Dec 31, 2025 | 1.26 Bn |
| Sep 30, 2025 | 1.38 Bn |
| Jun 30, 2025 | 1.35 Bn |
| Mar 31, 2025 | 1.17 Bn |
| Dec 31, 2024 | 1.15 Bn |
| Sep 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | 1.10 Bn |
| Mar 31, 2024 | 1.06 Bn |
| Dec 31, 2023 | 1.04 Bn |
| Sep 30, 2023 | 1.02 Bn |
| Jun 30, 2023 | 953.00 Mn |
| Mar 31, 2023 | 928.70 Mn |
| Dec 31, 2022 | 915.50 Mn |
| Sep 30, 2022 | 915.50 Mn |
| Dec 31, 2021 | 6.70 Mn |
API Access
Regeneron Pharmaceuticals Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();